is trulicity a glp-1 receptor agonists – Peripheral Brain Continued growth for GLP-1 receptor

Yes the semaglutide molecule is the same

Body composition is one of the best indicators of overall health, linked to risks for cardiovascular disease, diabetes, osteoporosis, and more

GLP-1 RAs have demonstrated benefits in coronary artery disease, heart failure, blood pressure, and atrial fibrillation irrespective of type 2 diabetes mellitus status, with new possible applications in peripheral arterial disease

CVD, cardiovascular disease

The percentage of participants who had weight reduction of 5% or more was 85%, 89%, and 91% with 5 mg, 10 mg, and 15 mg of tirzepatide, respectively, and 35% with placebo

semaglutide improved body weight, quality of life, and 6MWD in obese patients with heart failure with reduced ejection fraction (HFpEF) and T2DM, likely mediated through weight loss [34]